MOUNTAIN VIEW, Calif.,
May 6, 2021 /PRNewswire/
-- Aditx Therapeutics, Inc. (Aditxt) (the "Company") (Nasdaq:
ADTX), a biotech innovation company focused on improving the health
of the immune system, today announced that Meridian Health Services
Network (Meridian HSN) will offer AditxtScore™ for COVID-19 to its
network of healthcare provider partners.
Aditxt is pioneering the development of a new technology
platform that provides a personalized, comprehensive profile of the
immune system. By assessing an individual's immune biomarkers,
AditxtScore will be able to measure indications of immunity to
specific disease. AditxtScore applications include the recently
commercialized AditxtScore for COVID-19, developed for use in
detecting antibodies and neutralizing antibodies against SARS-CoV-2
antigens. Other applications under development include, among
others, predicting dynamic monitoring of the immune system in
infectious and autoimmune diseases, organ transplantation, gut
health, and allergy.
"While COVID-19 vaccines will be critical tools for an end to
the pandemic, monitoring the immune system's response is key to
understanding a person's level of protective immunity," said
Amro Albanna, co-founder and CEO of
Aditxt. "Key stakeholders will need to adapt to emerging data and
new variants both in the US and around the world, and the
AditxtScore platform potentially represents an important
complement. We are thrilled to add Meridian HSN to our growing
AditxtScore Channel Partner network with an opportunity to support
its clients, including national hotel chains, aviation and hospital
networks."
AditxtScore for COVID-19 will be included in Meridian HSN's
Mobile COVID-19 Antibody testing and telemedicine services to offer
a more robust point of care health option to meet their employees'
healthcare needs. As an AditxtScore Channel Partner, Meridian HSN
employer clients will have the ability to track the immune response
of their employees to provide a safer environment as people return
to work.
David Bloom, CEO of
Meridian Health Services Network, said, "Our goal is to
provide the most robust COVID-19 testing services to our partners
to ensure every employee and their families can access the proper
care to protect themselves. Aditxt's innovative immune monitoring
technology provides a comprehensive look at an individual's
protective immunity against COVID-19 and we're pleased to add it to
our roster of health tests for our clients."
About Aditxt Score for COVID-19
AditxtScore for
COVID-19 platform provides an informative and comprehensive profile
of the immune response to COVID-19 and related treatment and
vaccines in a single test, rather than relying on multiple tests.
The platform identifies and measures specific cellular responses,
including T cell activation, cytokine production and B cell
receptors, to determine long-lasting immunity following natural
infection or vaccination. Generalized population levels that track
the total number vaccinated may not provide an accurate safeguard
against the spread of the virus. AditxtScore for COVID-19 focuses
on a patient's immunity on whether they are protected from
infection to help them make informed health decisions including
travel, participate in group gatherings or return to work. Aditxt
is seeking 510(K) marketing authorization from AditxtScore.
Currently AditxtSocre is not FDA cleared but specimens are
processed at Aditxt's CLIA-certified AditxtScore Center.
For more information on AditxtScore and how it can bolster
COVID-19 testing efforts, visit aditxtscore.com
About Aditx Therapeutics
Aditxt is developing
technologies specifically focused on improving the health of the
immune system through immune monitoring and reprogramming. Aditxt's
immune monitoring technology is designed to provide a personalized
comprehensive profile of the immune system. Aditxt's immune
reprogramming technology is currently at the pre-clinical stage and
is designed to retrain the immune system to induce tolerance with
an objective of addressing rejection of transplanted organs,
autoimmune diseases, and allergies. For more information, please
visit: www.aditxt.com
About Meridian Health Services Network
Meridian Health
Services Network's mission for over 20 years is to create lasting
and impactful healthcare solutions for our clients. These range
from health and wellness, on-site services to healthcare financial
funding. For additional information/news inquiries, please
visit www.meridianhsn.com or reach out directly at
1.800.994.1143.
Forward-Looking Statements
Certain statements in this
press release constitute "forward-looking statements" within the
meaning of federal securities laws. Forward looking statements
include statements regarding the Company's intentions, beliefs,
projections, outlook, analyses or current expectations concerning,
among other things, the Company's ongoing and planned product and
business development; the Company's intellectual property position;
the Company's ability to develop commercial functions; expectations
regarding product launch and revenue; the Company's results of
operations, cash needs, spending, financial condition, liquidity,
prospects, growth and strategies; the industry in which the Company
operates; and the trends that may affect the industry or the
Company. Forward-looking statements are not guarantees of future
performance and actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors, as well as those risks more fully
discussed in the section titled "Risk Factors" in the Company's
most recent Annual Report on Form 10-K, as well as discussions of
potential risks, uncertainties, and other important factors in the
Company's other filings with the Securities and Exchange
Commission. All such statements speak only as of the date made, and
the Company undertakes no obligation to update or revise publicly
any forward-looking statements, whether as a result of new
information, future events or otherwise.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aditxt-signs-channel-partner-agreement-with-meridian-hsn-to-make-aditxtscore-for-covid-19-available-to-its-network-of-healthcare-provider-partners-301285399.html
SOURCE Aditx Therapeutics